Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...

And as we’ve been saying, we think fifty mg QT is getting towards the top of the dose response curve and the flat part of the dose ... they would just tell you that just the titration up and down is a ...

While Karl Fischer (KF) titration is known as the champion of battery manufacturing quality control, techniques such as ...

Kim Kardashian flaunted her toned, curvy figure in a skimpy two-piece via Instagram on Saturday. In a small collection of photos, the Skims co-founder, who recently dropped a new swimsuit ...

Latin popstar Danna begins a new chapter as CEO of a boutique label with producer and singer-songwriter Hoyer as chief music officer Latin pop artist Danna was only six years old when she released ...

The U.S. Treasury yield curve, one of the most reliable signals of recession, is flashing red again. As of March 2025, the spread between the 10-year and 2-year Treasury yields remains inverted ...

Good morning and welcome everyone to the Liquidia Corporation full year 2024 financial result and corporate update conference call. My name is Shannon, and I will be your conference operator today.

And then on -- given the 505(b)(2) pathway, should we expect any differences in the label for YUTREPIA versus TYVASO DPI? I know in the past you've mentioned demonstrating titration to 3 times ...

Liquidia Technologies Inc. (LQDA), with a market capitalization of $1.25 billion, reported its financial results for Q4 2024, revealing a larger-than-expected net loss and a revenue shortfall ...

Talphera Inc (TLPH) reported its Q4 2024 financial results, highlighting a strategic focus on cost management and clinical advancements. The company, which is pioneering new treatments in the renal ...

Traws Pharma Inc. (TRAW) saw a 4.16% increase in its stock price following its Q1 2025 earnings call, reflecting positive investor sentiment driven by promising updates in its antiviral drug ...